에 대한 최신 뉴스 Leidos Holdings (NYSE:LDOS) 주식

LEIDOS HOLDINGS INC

Leidos Holdings

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Xpeng g6 SUV

Large Cap

News

Movers

ABBV

CACI

LDOS

MNDY

MPWR

MRNA

NVDA

PCVX

SMCI

XPEV

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 모놀리식 파워 시스템즈(NASDAQ:MPWR)의 주식은 24.68% 하락했다. 이는 엣지워터 리서치(Edgewater Research)의 분석 보고서에 따라 모놀리식의 엔비디아(NASDAQ:NVDA) 블랙웰(Blackwell) GPU에 대한 할당이 전력 관리 IC의 성능 문제로 위험에 처해 있다고 밝힌 후 발생한 일이다.

슈퍼 마이크로, 모더나 및 샤오펑은 지난주 최악의 성과를 보인 10개 대형주 중 일부 (11월 11일-15일)

jerome powell ai14

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Bonds

Broad U.S. Equity ETFs

Specialty ETFs

Commodities

Currency ETFs

Treasuries

Economics

Federal Reserve

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

FSLR

PowerShares DB US Dollar Index Bullish Fund

WYNN

목요일(14일) 제롬 파월 연방준비제도 의장의 예상치 못한 매파적 발언이 시장을 뒤흔들었다. 미국 주요 주가지수는 하락세로 마감했고 달러는 5일 연속으로 급등했다.
파월 의장은 댈러스 비즈니스 리더들을 대상으로 한 연설에서 미국 경제의 놀라운 강점을 강조하며 연준이 &#34;금리인하를 서두를 필요가 없다&#34;고 말했다.

시장 뒤흔든 파월 연준 의장의 매파적 발언: 주가 하락, 달러 급등, 비트코인 하락

Leidos Holdings Inc

RESTON, Va., April 3, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4395237-1&amp;h=847953387&amp;u=https%3A%2F%2Fwww.leidos.com%2F&amp;a=Leidos">Leidos</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) today announced a new contract to provide signals intelligence (SIGINT) capabilities, engineering, analysis and reporting tools to the National Security Agency (NSA). The base year plus four option years single-award contract has a ceiling value of $390 million.
Leidos will perform a wide range of technical, engineering, systems administration and management functions. Tasks include delivery of SIGINT capabilities, analysis and reporting tool modifications, engineering services, lab and testbed management, integration and testing, deployment, training, and sustainment of a subset of NSA systems.
"Tailored and unique SIGINT solutions for the military and intelligence community are critical to delivering information superiority at speed," said Roy Stevens, Leidos National Security Sector president. "This contract will leverage Leidos' engineering and technical expertise, as we expand our work with the NSA."
Leidos combines expertise in cyber and IT managed services, as well as radar, sensors and other technologies, to develop SIGINT technologies, with end-users always in mind. Those technologies include resilient communications that operate through interruption to keep critical mission data flowing.

Contracts

Leidos Receives $390M NSA Signals Intelligence Contract

Analyst Ratings

Trading Ideas

Live On CNBC, Steve Weiss Buys More Leidos Holdings

Shares of Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) tumbled over 7% in premarket trade on Monday after the Pentagon canceled a $280 million over-budget HR project involving Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) and Leidos Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) on Friday.
What Happened: The U.S. Department of Defense&#8217;s cancellation of Oracle&#8217;s HR software, driven by delays and cost overruns, has triggered investor anxiety about broader government tech spending cutbacks.
This concern negatively impacted Palantir&#8217;s stock, as the company relies heavily on government contracts, including those with the DoD, which recently announced an additional $580 million in budget reductions.
Apart from this, Goldman Sachs analyst Gabriela Borges maintained a neutral rating on Palantir with a price target of $80, highlighting its strong Ontology and AI platform. However, she noted concerns about potential future competition from companies developing in-house AI and Palantir&#8217;s high valuation.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/03/44555936/scott-bessent-has-worst-job-in-the-world-today-says-black-swan-author-nassim-taleb-as-treasury-secretary-knows-the-implications-of-steep-tariffs" target="_blank" rel="noreferrer noopener">Scott Bessent Has ‘Worst Job In The World Today,' Says Black Swan Author Nassim Taleb, As Treasury Secretary Knows The Implications Of Steep Tariffs</a>
Why It Matters: Palantir provides data analytics tools to government customers for intelligence gathering, counterterrorism, and military purposes. The stock was down 7.04% to $79.81&nbsp;apiece in premarket trading. 
Palantir&#8217;s stock plummeted in early February due to proposed defense budget cuts by 8% annually for five years and CEO Alex Karp&#8216;s planned sale of up to 9.98 million shares.
PLTR's market capitalization stood at $170.18 billion as of Dec. 31, 2024, and it currently stands at $201.26 billion. This represents a growth of $31.08 billion or 18.26% on a year-to-date basis.
The stock recently <a href="https://www.benzinga.com/markets/equities/25/03/44451697/palantir-ceo-alex-karps-technological-republic-vision-faces-harvard-economists-critique-contemptuous-of-markets">joined the S&amp;P 100</a> on March 24, during the S&amp;P during its quarterly rebalancing. 
Price Action: Its stock price has risen by 14.18% in 2025, whereas it has gained 275.55% over the year. However, it is still 31.54% down from its 52-week high of $125.41 apiece.
Benzinga's Edge Rankings show a strong price momentum in the medium and long term, but it is weak in the short term. Its momentum ranking was sturdy at the 98.96th percentile. Whereas, the growth ranking, which combines historical expansion in earnings and revenue across multiple periods, was also solid at the 87.14th percentile. Check out its valuation scores and <a href="https://www.benzinga.com/report/PLTR">other fundamentals here</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/report/PLTR"><img loading="lazy" decoding="async" width="804" height="129" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080415/PLTR-edge-new.png" alt="" class="wp-image-849068" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080415/PLTR-edge-new.png 804w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080415/PLTR-edge-new-300x48.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080415/PLTR-edge-new-768x123.png 768w" sizes="(max-width: 804px) 100vw, 804px" /></a></figure>
Its consensus price target was $69.57, with a ‘sell' rating, based on the <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings">25 analysts tracked by Benzinga</a>. The price targets ranged from a low of $7.5 to a high of $125. The latest ratings from Loop Capital and Wedbush averaged $128.67, implying a 60.97% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/PLTR/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="384" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080446/PLTR-ANR-latest-1024x384.png" alt="" class="wp-image-849069" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080446/PLTR-ANR-latest-1024x384.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080446/PLTR-ANR-latest-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080446/PLTR-ANR-latest-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31080446/PLTR-ANR-latest.png 1075w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44554923/goldman-sachs-warns-us-stocks-are-at-risk-of-further-declines-but-policy-pivot-from-trump-or-fed-could-stoke-recovery" target="_blank" rel="noreferrer noopener">Goldman Sachs Warns US Stocks ‘Are At Risk Of Further Declines,&#8217; But Policy Pivot From Trump Or Fed Could Stoke Recovery</a></li>
</ul>
Image via Shutterstock

Analyst Color

Government

Market Summary

Regulations

Futures

Markets

General

ORCL

PLTR

PLTR Stock Falls Over 7% In Monday Pre-Market: What's Going On?

WIIM

Leidos Holdings shares are trading lower following a Bloomberg report indicating the Department of Defense will terminate a contract with the company and Oracle.

&nbsp;<a href="https://www.leidos.com/">Leidos</a> was awarded an $8.8 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop&nbsp;<a href="https://www.darpa.mil/research/programs/intelligent-generation-tools-security">Intelligent Generation of Tools for Security (INGOTS)</a>. INGOTS is a program to develop automated analyses to protect mobile operating systems from high-severity chained vulnerabilities in mobile device software, thereby enabling timely discovery and mitigation of dangerous vulnerabilities in mobile devices. INGOTS will help secure the mobile operating systems and applications.

Leidos Awarded $8.8M Contract From The Defense Advanced Research Projects Agency To Develop Intelligent Generation Of Tools For Security

ALLE

AMTM

ARRY

AXON

CARR

CHRW

ELPW

EXPD

ICON

PAYC

PCAR

PLUG

SAIC

SPPL

SRFM

SUNE

VSTE

Shares of companies within the broader industrial sector are trading higher amid ongoing volatility, possibly related to tariff delays.

Wells Fargo analyst Matthew Akers maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Overweight and lowers the price target from $197 to $191.

Price Target

Wells Fargo Maintains Overweight on Leidos Holdings, Lowers Price Target to $191

Tech

Leidos Partners With AI Company SeeTrue To Improve The Efficiency Of Airport Security And Customs Screenings

On February&nbsp;24, 2025, Leidos Holdings, Inc. (the "Company") announced it has entered into an accelerated share repurchase agreement (the "ASR Agreement") to repurchase $500&nbsp;million of the Company's common stock. These repurchases will be conducted under the Company's ongoing share repurchase authorization.
Pursuant to the ASR Agreement, the Company made an initial payment of $500&nbsp;million to the counterparty financial institution on February&nbsp;20, 2025 and received on the same day initial deliveries of approximately 3&nbsp;million shares of the Company's common stock from the counterparty. The final number of shares to be repurchased by the Company will be based on the volume-weighted average stock price of the Company's common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR Agreement. At settlement, under certain circumstances, the counterparty may be required to deliver additional shares of common stock to the Company, or under certain circumstances, the Company may be required to deliver shares of common stock or to make a cash payment, at its election, to the counterparty. The final settlement under the ASR Agreement is expected during the second quarter of 2025, subject to an earlier completion at the counterparty's option.

Buybacks

Leidos Announces $500M Accelerated Share Repurchase Agreement, Buys Back 3M Shares, Final Settlement Expected in Q2 2025

William Blair analyst Louie DiPalma downgrades Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) from Outperform to Market Perform.

Downgrades

William Blair Downgrades Leidos Holdings to Market Perform

Truist Securities analyst Tobey Sommer maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and lowers the price target from $185 to $165.

Truist Securities Maintains Buy on Leidos Holdings, Lowers Price Target to $165

UBS analyst Gavin Parsons maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Neutral and lowers the price target from $162 to $156.

UBS Maintains Neutral on Leidos Holdings, Lowers Price Target to $156

In the latest quarter, 7 analysts provided ratings for Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $183.71, a high estimate of $205.00, and a low estimate of $153.00. A 13.0% drop is evident in the current average compared to the previous average price target of $211.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1739368840_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Leidos Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$197.00</td>
<td>$199.00</td>
</tr>
<tr>
<td>Gautam Khanna</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$165.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$199.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Gavin Parsons</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$153.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Gavin Parsons</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$182.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$185.00</td>
<td>$205.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Leidos Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Leidos Holdings compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Leidos Holdings's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Leidos Holdings's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LDOS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Leidos Holdings analyst ratings.</a>
<h2>Unveiling the Story Behind Leidos Holdings</h2>
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.
<h3>Leidos Holdings's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining Leidos Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.86% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Leidos Holdings's net margin excels beyond industry benchmarks, reaching 8.69%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.03%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Leidos Holdings's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.77% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 1.11, Leidos Holdings adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Leidos Holdings: Insights From 7 Financial Analysts

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/02/11/final-trades-trade-desk-leidos-holdings-astrazeneca-and-devon-energy.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management named The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) as <a href="https://www.benzinga.com/quote/TTD/earnings">his final trade</a>.
Trade Desk, meanwhile, will release its fourth-quarter financial results after the closing bell today. Analysts expect the Ventura, California-based company to report quarterly earnings at 57 cents per share, up from 41 cents per share in the year-ago period. Trade Desk projects quarterly revenue of $759.56 million, compared to $605.8 million a year earlier, according to data from Benzinga Pro.
Stephen Weiss of Short Hills Capital Partners said he is staying with Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>).
Supporting his view, on Tuesday Leidos Holdings reported fourth-quarter fiscal 2024 revenue growth of 10% year-over-year to $4.37 billion, beating the analyst consensus estimate of $4.13 billion. Demand across all customer segments, especially for managed health services, drove the increase.
Don't forget to check out our<a href="https://www.benzinga.com/premarket/"> premarket coverage here</a>
Jim Lebenthal of Cerity Partners said AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) made a strong start to the year.
Adding support to his choice, AstraZeneca, on Feb. 6, reported fourth-quarter earnings and revenue above estimates. Sales of $14.89 billion, up 18% year over year (+19% at constant currency), topped the consensus of $14.29 billion.
Rounding out the trades, Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said with oil above $70, Devon Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) is wildly profitable.
Supporting her view, Piper Sandler analyst Mark Lear, on Jan. 29, maintained Devon Energy with an Overweight rating and raised the price target from $53 to $54.
Price Action:
<ul>
<li>Trade Desk shares declined 1.9% to close at $120.21 on Tuesday.</li>
<li>Leidos shares fell 3.6% to settle at $137.60 during Tuesday's session.</li>
<li>AstraZeneca shares gained 0.1% to close at $72.73 on Tuesday.</li>
<li>Devon Energy shares gained 2.5% to settle at $35.12 during the session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

Trade Desk, Leidos, Devon Energy And A Major Health Care Stock On CNBC's 'Final Trades'

Wells Fargo analyst Matthew Akers maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Overweight and lowers the price target from $199 to $197.

Wells Fargo Maintains Overweight on Leidos Holdings, Lowers Price Target to $197

U.S. stocks edged marginally lower on Tuesday after Federal Reserve Chair Jerome Powell reiterated that the central bank is in no hurry to cut interest rates during his testimony before the Senate Banking Committee, offering little <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43628752/feds-powell-reiterates-no-hurry-to-cut-interest-rates-as-inflation-remains-somewhat-elevated">support for risk assets.</a>
Investors remained on edge ahead of Wednesday's key inflation report, with the Bureau of Labor Statistics set to release the January Consumer Price Index.
The S&amp;P 500 dipped 0.1%, the Nasdaq 100 declined 0.2%, and small-cap stocks underperformed. Bucking the trend, the Dow Jones Industrial Average posted a marginal 0.1% gain.
Company-wise, Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) surged 7%, after Vice President J.D. Vance indicated that artificial intelligence chips will be manufactured in the U.S.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell by over 4%, reaching the lowest levels in eleven weeks, pressured by weak January auto sales in China.
Geopolitical tensions flared as the European Union threatened countermeasures in response to President Donald Trump's announcement of 25% tariffs on aluminum and steel.
Long-dated Treasury yields moved higher, with the 10-year yield rising to 4.54%. Yet, the broader dollar index – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – weakened, down 0.2%. 
Gold paused for a breather, remaining flat at $2,900 per ounce. Oil prices inched up by 1%, eyeing the third straight session of gains. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) weakened 1.3% to $96,000. 
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,526.92</td>
<td>0.1%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,064.30</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,714.53</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,273.29</td>
<td>-0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;inched 0.1% down to $604.07.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was 0.1% up to $445.06.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 0.3% to $527.55.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.7% to $225.34.</li>
<li>The&nbsp;Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.4%; the&nbsp;Consumer Discretionary Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 1.2%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
<ul>
<li>Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) rose 2.4% after KeyBanc raised the stock to Overweight.</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) surged 5% after Elliott Investment Management urged the company to sell or spin off its midstream business, estimating its value at over $40 billion.</li>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) gained 2.8%, and Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) climbed 2% amid speculation about a potential AI partnership for iPhone users in China.</li>
</ul>
Stocks reacting to earnings reports include: 
<ul>
<li>S&amp;P Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>): up 3.8%</li>
<li>Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>): up 7.5%</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): up 3.7%</li>
<li>DuPont de Nemours Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>): up 7.8%</li>
<li>Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>): down 5.6%</li>
<li>Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>): down 6.5%</li>
<li>Masco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>): up 0.6%</li>
<li>WK Kellogg Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>): down 0.7%</li>
<li>Arvinas Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>): down 6.3%</li>
<li>AutoNation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>): down 3.3%</li>
<li>Carlyle Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>): down 4.7%</li>
<li>Carrier Global Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>): down 1.8%</li>
<li>Fidelity National Information Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>): down 14.9%</li>
<li>GlobalFoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>): up 6.2%</li>
<li>IPG Photonics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPGP#NASDAQ">IPGP</a>): down 5.9%</li>
<li>LCI Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>): up 3.5%</li>
<li>Leidos Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>): down 5.4%</li>
<li>MYT Netherlands Parent BV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYTE#NYSE">MYTE</a>): up 19.4%</li>
<li>NNN REIT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>): up 5.8%</li>
<li>Royalty Pharma Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>): up 1.4%</li>
<li>Sunoco LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUN#NYSE">SUN</a>): down 1.8%</li>
<li>TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>): down 3.5%</li>
<li>USA Compression Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USAC#NYSE">USAC</a>): down 2.9%</li>
<li>Wesco International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCC#NYSE">WCC</a>): up 2.1%</li>
</ul>
Companies reporting after the close include:
<ul>
<li>American International Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>)</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</li>
<li>Welltower Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>)</li>
<li>Assurant Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>)</li>
<li>Primerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>)</li>
<li>Allison Transmission Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>)</li>
<li>Edwards Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>)</li>
<li>Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>)</li>
<li>Brighthouse Financial Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>)</li>
<li>DoorDash Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NYSE">DASH</a>)</li>
<li>W. P. Carey Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>)</li>
<li>Agree Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>)</li>
<li>Red Rock Resorts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>)</li>
<li>Teradata Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>)</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43632327/steel-stocks-breakout-analyst-sees-bullish-setup-for-us-steel-nucor-steel-dynamics">Tariffs Drive Steel Stock Gains As Analyst Highlights Catalysts For Nucor, US Steel</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Sector ETFs

Econ #s

AAPL

ALSN

ARVN

BABA

Brighthouse Financial, Inc. - Common Stock

DASH

GILD

INTC

IPGP

LCII

MYTE

RPRX

SPGI

STLD

TSLA

USAC

WELL

Select Sector SPDR-Consumer Discretionary

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?

On Tuesday, Leidos Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) reported fourth-quarter fiscal 2024 revenue growth of 10% year-over-year to $4.37 billion, beating the <a href="https://www.benzinga.com/pressreleases/25/02/n43617405/leidos-posts-strong-fourth-quarter-and-fiscal-year-2024-results" target="_blank" rel="noreferrer noopener">analyst consensus estimate of $4.13 billion</a>. Demand across all customer segments, especially for managed health services, drove the increase. 
The defense, aviation, information technology and biomedical research, the company&#8217;s adjusted EPS was $2.37, up 19% year-over-year, beating the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate of $2.27</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43533402/roblox-q4-earnings-topline-and-user-growth-miss-estimates-fy25-outlook-lags-stock-slides" rel="noreferrer noopener">Roblox Q4 Earnings: Topline And User Growth Miss Estimates, FY25 Outlook Lags, Stock Slides</a>
Adjusted net income was $316 million for the quarter, up 14% year-over-year.
Adjusted EBITDA was $508 million, up 12% year over year. The margin of 11.6% increased from 11.4% a year ago.&nbsp;
Net bookings totaled $7.6 billion for the quarter, representing a book-to-bill ratio 1.7.&nbsp;As a result, the backlog at the end of the year was $43.6 billion, of which $8.4 billion was funded.&nbsp;
Leidos held $943 million in cash and equivalents as of January&nbsp;3, 2025.
CEO Tom Bell said 2024 results came at or above the high end of its guidance range across all metrics, with the fourth quarter especially strong in revenue growth and business development. Also, its 2024 performance propelled the company beyond the three-year targets established at its 2021 Investor Day.
Outlook:&nbsp;Leidos expects fiscal 2025 revenue of $16.9 billion–$17.3 billion. The analyst <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus stands&nbsp;at $16.98 billion</a>.
The company expects its fiscal 2024 adjusted EPS of $10.35–$10.75 versus the&nbsp;$10.58 consensus.
Leidos Holdings stock surged 25% in the last 12 months. However, at least three Wall Street firms cut <a target="_blank" href="https://www.benzinga.com/quote/LDOS/analyst-ratings" rel="noreferrer noopener">their price target</a> on the stock since December 2024, including two downgrades of ratings by Goldman Sachs and TD Cowen.
Price Action: LDOS stock is up 0.16% at $143.00 premarket at last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43535385/thomson-reuters-q4-earnings-beats-estimates-boosts-dividend-10-ceo-highlights-strategic-growth" target="_blank" rel="noreferrer noopener">Thomson Reuters Q4 Earnings: Beats Estimates, Boosts Dividend 10%, CEO Highlights Strategic Growth</a></li>
</ul>
Photo: Shutterstock

Earnings

Leidos Q4 Earnings: $7.6 Billion In Net Bookings, CEO Highlights Business Momentum And 2025 Outlook

Leidos Holdings shares are trading higher after the company reported Q4 earnings and revenue above estimates.

Leidos is initiating fiscal year 2025 guidance as specified in the table below.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Measure</td>
<td colspan="1" rowspan="1">FY25 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues (billions)</td>
<td colspan="1" rowspan="1">$16.9 - $17.3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA Margin</td>
<td colspan="1" rowspan="1">Mid-High 12%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP Diluted EPS</td>
<td colspan="1" rowspan="1">$10.35 - $10.75</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Leidos Holdings Expects FY25 Revenue Of $16.9B-$17.3B Vs $16.98B Est, Adj EPS Of $10.35-$10.75 Vs $10.58 Est

Earnings Beats

Leidos Holdings Q4 2024 Adj. EPS $2.37 Beats $2.27 Estimate, Sales $4.365B Beat $4.134B Estimate

Press Releases

Leidos and SeeTrue Collaborate to Advance AI-Powered Threat Detection Technology Across Market Sectors

Leidos Named to World's Most Ethical Companies List for Eighth Consecutive Year

NUBURU Makes Strategic Move into Defense Market with Groundbreaking Acquisition

Hampton University Expands Board of Trustees with Four Visionary Leaders in Media, Finance, Tech & Law

Leidos appoints Adam Clarke chief executive for Leidos UK & Europe

Frequency Electronics Awarded Subcontract from Leidos to Develop Advanced Nitrogen Vacancy Diamond Magnetometer for DIU's Transition Quantum Sensing Program

Leidos completes successful test launch of a Small Cruise Missile

Leidos hires Daryle Lademan to lead corporate strategy activities

NUBURU's (BURU) Strategic Leap: Expanding into Defense Technology with Innovative Laser Solutions

Leidos awarded $390 million NSA signals intelligence contract

BAESY

BURU

FEIM

Amentum Holdings

Booz Allen Hamilton Holding Corporation Common Stock

Booz Allen Hamilton

CACI International, Inc. Class A Common Stock

CACI International

CBIZ

Clarivate

CRA Intl

Dun & Bradstreet Holdings, Inc. Common Stock

Dun & Bradstreet Holdings

Equifax

Exponent

FTI Consulting

Huron Consulting Group Inc. - Common Stock

Huron Consulting Gr

ICF International

Innodata

Jacobs Solutions

LegalZoom.com

NV5 Global

Planet Labs

Parsons

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX

Science Applications International Corporation - Common Stock

Science Applications Intl

Acuren

TransUnion

UL Solutions

Verisk Analytics

Wells Fargo

Truist Securities

TD Cowen

Goldman Sachs

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 모놀리식 파워 시스템즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>)의 주식은 24.68% 하락했다. 이는 엣지워터 리서치(Edgewater Research)의 분석 보고서에 따라 모놀리식의 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) 블랙웰(Blackwell) GPU에 대한 할당이 전력 관리 IC의 성능 문제로 위험에 처해 있다고 밝힌 후 발생한 일이다.
2. 슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)의 주식은 24.23% 하락했다. 이는 회사가 최근  <a href="https://www.benzinga.com//node/41938588" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">2024년 9월 30일 종료 분기 보고서를 제때</a> 제출할 수 없다고 발표한 후 주가가 급락했다.
3. 모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)의 주식은 21.31% 하락했다. 이는 도널드 트럼프 대통령 당선인이 로버트 F. 케네디 주니어를 보건복지부(HHS) 장관으로 지명한 후 <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">백신 주식에 대한 압박</a>이 발생했기 때문이다.
4. 레이도스 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>)의 주식은 19.04% 하락했다. 이는 트럼프 대통령 당선인이 인수 기간 동안 연방 정부 주요직 임명을 했기 때문으로, 투자자들은 &#8220;<a href="https://www.benzinga.com//node/42013424" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">정부 효율성 부서</a>&#8220;에서의 가능한 삭감의 영향을 평가할 수 있다.
5. 먼데이닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>)의 주식은 회사가 3분기 실적이 예상치를 웃돌고 연간 전망을 상향 조정했음에도 <a href="https://www.benzinga.com//node/41877454" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">불구하고</a> 지난주 18.94% 하락했다.
6. 백스사이트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>)의 주식은 18.60% 하락했다. 이는 도널드 트럼프 대통령 당선인이 로버트 F. 케네디 주니어를 HHS 장관으로 지명한 후 백신 주식에 대한 압박이 발생했기 때문이다.
7. 부즈 앨런 해밀턴 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>)의 주식은 18.59% 하락했다.
8. 애브비(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)의 주식은 17.30% 하락했다. 이는 2상 EMPOWER 시험이 <a href="https://www.benzinga.com/general/biotech/24/11/41881546/abbvie-9billion-schizophrenia-studies-bristol-myers-stock-surges" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주요 목표</a>를 달성하지 못했다고 발표한 후 발생한 일이다.
9. CACI 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>)의 주식은 17.16% 하락했다.
10. 샤오펑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>)의 주식은 16.89% 하락했다. 이는 미국에 상장된 중국 주식의 광범위한 하락세를 반영한 것이다. 이러한 시장 변화는 트럼프 당선인의 행정부 인사를 둘러싼 우려의 영향을 받을 수 있으며, 이는 <a href="https://www.benzinga.com//node/41946780" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">중국에 대한 더욱 강경한 입장</a>을 나타낼 수 있다.
또한 읽어보세요:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%87%BC%ED%94%BC%ED%8C%8C%EC%9D%B4-%EB%94%94%EC%A6%88%EB%8B%88-%EB%B0%8F-%EC%BD%94%EC%9D%B8%EB%B2%A0%EC%9D%B4%EC%8A%A4%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC/" target="_blank" rel="noopener">쇼피파이, 디즈니 및 코인베이스는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (11월 11일-15일)</a></li>
</ul>
이미지 출처: Robert Way via Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

목요일(14일) 제롬 파월 연방준비제도 의장의 예상치 못한 매파적 발언이 시장을 뒤흔들었다. 미국 주요 주가지수는 하락세로 마감했고 달러는 <a href="https://www.benzinga.com/topic/interest-rates" target="_blank" rel="noopener">5일 연속으로</a> 급등했다.
파월 의장은 댈러스 비즈니스 리더들을 대상으로 한 연설에서 미국 경제의 놀라운 강점을 강조하며 연준이 "금리인하를 서두를 필요가 없다"고 말했다.
그는 2% 인플레이션 목표 달성을 위한 연준의 노력을 거듭 강조하면서 인플레이션이 원하는 수준 이상으로 유지되고 있는 만큼 신중한 의사 결정이 필요하다고 강조했다. 또한 생산성 향상을 강조하며 "지난 5년 동안 팬데믹 이전 20년 동안 어느 시점보다 빠르게 성장했다"며 미국 경제가 "주요 경제국 중 가장 좋은 성과를 내고 있다"고 말했다.
파월 의장은 10월 <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41971830/producer-inflation-rises-more-than-expected-in-october-should-traders-rethink-interest-rate-cut-path" target="_blank" rel="noopener">생산자물가지수(PPI) 상승</a>에 대해 "단순한 상승 이상"이라고 평가하면서도 2% 인플레이션 목표를 향한 궤도에 대한 자신감을 유지했다.
<h3 class="wp-block-heading">시장은 금리 경로 재평가: 트레이더들 12월 금리인하 확률 낮춰</h3>
파월 의장의 발언은 금리 시장에 영향을 미쳤으며, 현재 연방기금 선물은 12월 25bp 인하 가능성을 낮게 반영하고 있다. CME FedWatch 도구에 따르면 이날 오전 약 80%였던 금리인하 확률은 58%로 급락했다.
SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)로 추적되는 S&amp;P 500 지수는 0.6% 하락 마감하여 지난주 금리인하로 인한 상승분을 완전히 상실했다. 에너지 섹터는 유일하게 상승해 0.4% 올랐고, 산업과 헬스케어 섹터는 각각 0.7% 하락하며 하락세를 주도했다.
S&amp;P 500에서 최고 성과를 거둔 종목은 테피스트리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>), 윈 리조트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>), 퍼스트 솔라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>)로 각각 12.8%, 8.7%, 7.2% 상승했다. 반면 레이도스 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>)와 슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)는 각각 13.6%와 11.4% 하락했다.
Invesco QQQ Trust(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)로 추적되는 기술 섹터는 0.7% 하락하며 4일 연속 하락세를 기록했다. SPDR 다우존스 산업평균지수 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)가 추적하는 우량주는 0.5% 하락했고, iShares 러셀 2000 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>)가 추적하는 소형주는 1.3% 하락하며 부진한 성적을 보였다.
달러는 계속해서 유동성을 끌어모았고, Invesco DB USD Index Bullish Fund ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>)는 5일 연속 상승세를 기록하며 2023년 10월 말 이후 최고 수준에 도달했다.
국채수익률도 상승하여 10년물 수익률이 4.46%로 마감했다. SPDR 금 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>)로 추적되는 금 가격은 5일 연속 하락했다.
암호화폐 시장에서 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)는 24시간 동안 1.7% 하락하여 오후 5:21(ET) 기준으로 88,013달러에서 거래되며 11월 최악의 일간 실적을 보일 수 있다.
다음 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/economy/%EA%B8%80%EB%A1%9C%EB%B2%8C-%ED%8E%80%EB%93%9C%EB%A7%A4%EB%8B%88%EC%A0%80-%EC%84%A4%EB%AC%B8%EC%A1%B0%EC%82%AC-%ED%8A%B8%EB%9F%BC%ED%94%84-%EC%8A%B9%EB%A6%AC%EB%8A%94-%EC%84%B1%EC%9E%A5-%EC%86%8C/" target="_blank" rel="noopener">트럼프 승리는 성장, 소형주 및 미국 달러에 대한 투자자 낙관론 촉발: BofA 설문조사</a>
이미지 출처: Midjourney를 통해 AI로 생성한 이미지  
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Leidos Holdings

뉴스

에 대한 최신 뉴스 Leidos Holdings (NYSE:LDOS) 주식

일요일, 11월 17, 2024

금요일, 11월 15, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌